Physician

Michael H Veeder, MD

According to 2025 Medicare claims, Michael Veeder, MD (NPI: 1568463305) practices hematology/oncology in the Peoria, IL market, with the plurality of this provider's patient population coming from Tazewell, IL. This provider's primary affiliated billing organization is ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C (NPI: 1801896063; TIN: 371331017) and primary practice location at 61615-7822. Veeder is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Veeder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,252 traditional Medicare patients, billed 290,148 HCPCS/CPT codes, and received $4,014,619 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 3,601 prescription claims across 514 beneficiaries totaling $6,986,439 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 160 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,243,217 and ending at $4,014,619. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,813,165 to $6,986,439. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $25,040 to $5,839.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,777	275,032	$3,243,217
2016	1,607	215,954	$2,445,270
2017	1,764	269,195	$3,282,728
2018	1,735	260,519	$3,550,610
2019	1,901	302,529	$4,120,184
2020	1,528	310,766	$4,465,903
2021	1,462	276,633	$3,904,503
2022	1,248	211,608	$3,014,150
2023	1,314	271,599	$3,814,947
2024	1,252	290,148	$4,014,619

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	461	4,343	$1,813,165
2016	472	4,522	$2,652,012
2017	480	4,350	$2,910,942
2018	522	4,678	$3,417,794
2019	561	4,939	$4,095,913
2020	559	4,654	$4,109,589
2021	541	4,110	$4,384,847
2022	540	3,603	$5,277,152
2023	520	3,955	$6,984,779
2024	514	3,601	$6,986,439

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	57	430	$56,684
2016	53	229	$26,494
2017	16	122	$13,898
2018	20	145	$21,120
2019	29	217	$19,346
2020	41	282	$19,899
2021	13	293	$72,079
2022	N/R	120	$5,221
2023	23	203	$37,274
2024	N/R	160	$7,988

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	539	835	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	449	755	$12
80053	Blood test, comprehensive group of blood chemicals	349	832	$10
36415	Insertion of needle into vein for collection of blood sample	358	819	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	362	936	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	68	1,879	$1,346,999
Ibrance	Palbociclib	77	2,158	$1,140,374
Lenalidomide	Lenalidomide	56	1,540	$749,070
Calquence	Acalabrutinib Maleate	53	1,590	$746,519
Brukinsa	Zanubrutinib	45	1,324	$559,091

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	36	$3,289
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	13	$1,683
A5056	Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each	N	N/R	11	$871
J8521	Capecitabine, oral, 500 mg	N	N/R	23	$573
E1392	Portable oxygen concentrator, rental	Y	N/R	15	$498

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Michael H. Veeder, MD?

Tedicare shows public-source Medicare data for Michael H. Veeder, MD (NPI 1568463305), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael H. Veeder, MD have ACO affiliation data?

Michael H. Veeder, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Michael H. Veeder, MD?

Michael H. Veeder, MD is linked to ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C (billing NPI 1801896063) in the available physician profile data.

Does Michael H. Veeder, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.